Vir Biotechnology: Innovating Immunology to Fight Infectious Diseases & Boost Nasdaq Growth
Explore Vir Biotechnology’s rise as a San Francisco‑based immunology leader tackling viral & bacterial diseases, its Nasdaq valuation, and R&D‑driven future.
2 minutes to read
